BridgeBio Oncology Therapeutics, Inc.
BridgeBio Oncology Therapeutics, Inc. scores highest on Anchor (63) and lowest on Nitro (11). Its PosiPenta is 41.90 out of 100, around the middle of similar companies.
On the Penta Grid this week, BridgeBio Oncology Therapeutics, Inc. is Grid #472 of 837 in the Healthcare sector in United States, and Grid #2,699 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| BridgeBio Oncology Therapeutics, Inc. | 41.90 | 43 | 37 | 11 | 55 | 63 |
| Inhibikase Therapeutics, Inc. | 50.89 | 33 | 44 | 59 | 68 | 51 |
| Greenwich LifeSciences, Inc. | 38.62 | 1 | 47 | 46 | 45 | 54 |
| Lyell Immunopharma, Inc. | 34.94 | 41 | 32 | 20 | 37 | 45 |
| SIGA Technologies, Inc. | 58.32 | 34 | 87 | 32 | 78 | 60 |
| MacroGenics, Inc. | 35.53 | 14 | 34 | 69 | 18 | 43 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -40.29 |
| P/B ratio | 0.70 |
EEarnings
| Trailing EPS | ₹-6.63 |
| Forward EPS | ₹-257.21 |
NNitro
| Price | 267.10 |
| 52-week high | 1408.41 |
| 52-week low | 266.15 |
| Fall from 52-week high | 81.0% |
TTorque
| Return on equity (ROE) | -81.92% |
| Debt-to-equity | 0.01 |
AAnchor
| Beta (price swings) | 0.65 |
| Market cap | ₹2,141 Cr |
| Insider holding | 27.12% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is BridgeBio Oncology Therapeutics, Inc.'s PosiPenta score?
BridgeBio Oncology Therapeutics, Inc.'s PosiPenta is 41.90 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does BridgeBio Oncology Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, BridgeBio Oncology Therapeutics, Inc. is Grid #472 of 837 in the Healthcare sector in United States, and Grid #2,699 of 4,000 in United States.
Which PosiPenta pillar is strongest for BridgeBio Oncology Therapeutics, Inc.?
Anchor (stability and dividends), with a score of 63 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for BridgeBio Oncology Therapeutics, Inc.?
Nitro (momentum), with a score of 11 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.